Maria Pia Pistillo

CTLA-4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction

Elisabetta Contardi, Giulio Lelio Palmisano, Pier Luigi Tazzari et al. · International Journal of Cancer · 2005 · 323 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma

Ester Simeone, Giusy Gentilcore, Diana Giannarelli et al. · Cancer Immunology Immunotherapy · 2014 · 250 citations · Full text

Medicine, Immunology, Oncology +17

The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-α production

Stefania Laurent, Paola Queirolo, Silvia Boero et al. · Journal of Translational Medicine · 2013 · 163 citations · Full text

Life Sciences, Immunology, Oncology +17

Evaluation of CTLA-4 expression and relevance as a novel prognostic factor in patients with non-small cell lung cancer

Sandra Salvi, Vincenzo Fontana, Simona Boccardo et al. · Cancer Immunology Immunotherapy · 2012 · 134 citations · Full text

Medicine, Immunology, Oncology +15

CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells

Maria Pia Pistillo · Blood · 2002 · 126 citations

Life Sciences, Immunology, Oncology +17